Improved X‐ray diffraction from  Bacillus megaterium  penicillin G acylase crystals through long cryosoaking dehydration by Rojviriya, Catleya et al.
crystallization communications
1570 doi:10.1107/S1744309111040462 Acta Cryst. (2011). F67, 1570–1574





Improved X-ray diffraction from Bacillus
megaterium penicillin G acylase crystals through
long cryosoaking dehydration
Catleya Rojviriya,a Thunyaluck
Pratumrat,a Mark A. Saperb and
Jirundon Yuvaniyamaa*
aDepartment of Biochemistry and Center for
Excellence in Protein Structure and Function,
Faculty of Science, Mahidol University, Rama 6
Road, Phayathai, Bangkok 10400, Thailand,
and bDepartment of Biological Chemistry,
University of Michigan, Ann Arbor,
Michigan 48109-1055, USA
Correspondence e-mail: scjyv@mahidol.ac.th
Received 21 July 2011
Accepted 1 October 2011
Penicillin G acylase from Bacillus megaterium (BmPGA) is currently used in
the pharmaceutical industry as an alternative to PGA from Escherichia coli
(EcPGA) for the hydrolysis of penicillin G to produce 6-aminopenicillanic acid
(6-APA), a penam nucleus for semisynthetic penicillins. Despite the significant
differences in amino-acid sequence between PGAs from Gram-positive and
Gram-negative bacteria, a representative PGA structure of Gram-positive
origin has never been reported. In this study, crystallization and diffraction
studies of BmPGA are described. Poor diffraction patterns with blurred spots
at higher resolution were typical for BmPGA crystals cryocooled after a brief
immersion in cryoprotectant solution. Overnight soaking in the same cryo-
solution substantially improved both the mosaicity and resolution limit through
the establishment of a new crystal-packing equilibrium. A crystal of BmPGA
diffracted X-rays to 2.20 A˚ resolution and belonged to the monoclinic space
group P21 with one molecule of BmPGA in the asymmetric unit.
1. Introduction
Penicillin G acylase (PGA; penicillin amidohydrolase; EC 3.5.1.11),
also referred to as penicillin acylase class II, is an important enzyme
in the industrial production of semisynthetic penicillins, a widely used
class of -lactam antibiotics (Kresse et al., 2007). PGA hydrolyzes the
amide bond between the phenylacetyl side chain and the -lactam
nucleus of natural penicillin G to produce 6-aminopenicillanic acid
(6-APA), which is a key intermediate in the manufacture of a wide
range of semisynthetic penicillins. Its high selectivity in this single-
step conversion reaction makes the enzyme a cost-effective and
environmentally friendly alternative to conventional processes, which
involve multiple chemical reactions (Elander, 2003; Chandel et al.,
2008). Currently, the majority of deacylations in -lactam production
processes depend on PGA. Present developments indicate that the
enzyme can also be successfully exploited in a synthetic direction
(Bruggink et al., 1998; Alkema et al., 2003; Gabor et al., 2005; Gior-
dano et al., 2006). Subsequent production processes of valuable
antibiotics such as amoxicillin and ampicillin are based on the con-
densation of an appropriate d-()-amino-acid derivative with 6-APA
(Youshko & Svedas, 2000; Gonc¸alves et al., 2002; Gabor & Janssen,
2004; Giordano et al., 2006).
PGA is a heterodimeric protein that belongs to the N-terminal
nucleophile (Ntn) hydrolase family, a class of enzymes containing a
distinctive  structural motif with the N-terminal amino-acid
residue of the -chain serving as the nucleophile for catalysis
(Duggleby et al., 1995). It is produced as either an intracellular or
an extracellular enzyme by a variety of microorganisms. PGAs from
Gram-negative bacteria such as Escherichia coli (Cole, 1969),
Kluyvera cryocrescens (formerly K. citrophila; Barbero et al., 1986),
Providencia rettgeri (Klei et al., 1995) and Alcaligenes faecalis
(Verhaert et al., 1997) accumulate in the periplasmic space, whereas
PGAs from Gram-positive bacteria such as Arthrobacter viscosus
(Ohashi et al., 1988) and Bacillus megaterium (Chiang & Bennett,
1967) are generally secreted outside of the cells. Interestingly,
primary-structure analysis indicates that the PGAs of Gram-positive
and Gram-negative bacteria are distinct, although they belong to the
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same protein family. The observed differences suggest that PGA
from Gram-positive bacteria might represent a different evolutionary
branch of the -lactam acylases, such as the cephalosporin acylases
(Martı´n et al., 1995). To date, only crystal structures of PGAs from
Gram-negative bacteria such as E. coli and P. retteri have been
determined (Duggleby et al., 1995; Done et al., 1998; Alkema et al.,
2000; McVey et al., 2001).
Currently, PGA from B. megaterium ATCC14945 (BmPGA) is
preferred for industrial processes (Rajendhran & Gunasekaran,
2004). Its biotechnological applications have emerged as an alter-
native to the well known PGA from E. coli ATCC11105 (EcPGA)
because its extracellular secretion simplifies the downstream purifi-
cation process. BmPGA has only 30% amino-acid sequence identity
to EcPGA as well as to other PGAs from Gram-negative bacteria,
but has at least 97% identity to other PGAs from Gram-positive
counterparts. Recent research efforts have been focused on protein
engineering to improve the enzyme stability and to extend its sub-
strate specificity for synthetic applications. The lack of an experi-
mental structure of BmPGA has restricted such rational design to
information obtained from homology models (Yang et al., 2000;
Rajendhran & Gunasekaran, 2004; Wang et al., 2007; Chandel et al.,
2008), the reliability of which might be limited by the low sequence
similarity between BmPGA and the template structures. Therefore,
in this study an effort has been made to crystallize BmPGA in order
to elucidate its three-dimensional structure, which would facilitate
protein engineering. Unfortunately, poor diffraction patterns were
initially obtained from these BmPGA crystals. Instead of finding new
crystal forms that might exhibit better X-ray diffraction, a long cryo-
soak was tried, which substantially improved the diffraction quality of
the crystals. Here, we present the crystallization, post-crystallization
soaking and preliminary crystallographic studies of BmPGA.
2. Methods
2.1. Protein production and purification
BmPGA was produced as a secreted protein from the plasmid
pBA402 containing the PGA-producing gene (pac) of B. megaterium
UN1 in the pac mutant strain B. megaterium UN-cat (Panbangred et
al., 2000) with the following modifications. The bacterial cells were
grown overnight at 301 K with shaking at 250 rev min1 in Luria–
Bertani medium (LB) containing 10 mg ml1 kanamycin. A 2 ml
preculture was transferred into a culture flask of 200 ml modified LB
(1% peptone, 0.5% yeast extract, 0.1% sodium chloride) containing
kanamycin for batch preparation of the enzyme. Following continued
shaking for an additional 48 h, the extracellular medium was sepa-
rated from the cell culture by centrifugation for 20 min at 5000g.
After adjustment of the pH to 5.50, the supernatant was filtered
through a 0.45 mm PVDFmembrane (Durapore, Millipore) to remove
any fine particles as well as residual cells. The filtered BmPGA was
purified to homogeneity using an SP-Sepharose HP (GE Healthcare)
column pre-equilibrated with 50 mM sodium phosphate pH 5.50. The
bound BmPGA was eluted with a linear gradient of 0–1M sodium
chloride in 50 mM sodium phosphate pH 5.50 at room temperature.
The purity of the BmPGAwas determined by SDS–PAGE (Laemmli,
1970) and the enzyme activity was assayed as described previously
(Balasingham et al., 1972). Fractions containing BmPGAwere pooled
based on BmPGA purity and then dialyzed against 0.4M sodium
chloride in 50 mM sodium phosphate pH 5.50 at 277 K. The purified
protein was concentrated to 8–10 mg ml1 by ultrafiltration using
10 kDa cutoff centrifugal filter devices (Amicon, Millipore) and
stored at 277 K for use in crystallization trials.
2.2. Crystallization of BmPGA
Prior to crystallization-drop setup, the concentrated protein was
passed through a 0.22 mm centrifugal filter (Ultrafree-MC, Millipore)
to remove dust, microparticles and aggregated protein. Awide range
of conditions for BmPGA crystallization were initially screened in
60-well minitray plates (Nunc) using the modified microbatch method
(Chayen et al., 1992; D’Arcy et al., 1996). Crystallization drops were
set up by mixing an equal volume (1 ml) of protein solution with each
crystallization solution under mineral oil containing vitamin E (Babi
Mild Natural ’N Mild baby oil, Thailand; Chitnumsub et al., 2004).
Crystallization conditions producing crystals were further optimized
systematically in ComboPlates (Greiner Bio-One) using the hanging-
drop vapour-diffusion method (McPherson, 1999; Benvenuti &
Mangani, 2007). For data collection, BmPGA crystals were obtained
from drops consisting of 1 ml 8.6 mg ml1 protein solution and 1 ml
27%(m/v) PEG 4000, 0.2M CaCl2, 0.1M imidazole pH 6.50 that were
equilibrated against a 500 ml reservoir containing the same crystal-
lization solution. All crystallization trials for BmPGA were set up at
295 K.
2.3. X-ray data collection and processing
A crystal was scooped up in a nylon loop and soaked in a cryo-
protectant solution overnight prior to flash-cooling in a 98 K nitrogen
stream generated by an X-Stream 2000 low-temperature system
(Rigaku/MSC). X-ray diffraction data were collected at the Center
for Excellence in Protein Structure and Function (CPSF), Faculty
of Science, Mahidol University, Thailand. The X-ray radiation was
generated by a Rigaku RU-H3R rotating-anode X-ray generator
(Cu K;  = 1.5418 A˚) running at 50 kV and 100 mA equipped with
Osmic Confocal Max-Flux multi-layer optics and a 0.3 mm collimator.
Diffraction images were recorded on an R-AXIS IV++ image-plate
system (Rigaku/MSC). All diffraction data were indexed, integrated
and scaled using the CrystalClear/d*TREK program suite (Pflugrath,
1999).
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Figure 1
A monoclinic crystal of B. megaterium PGA of length 750 mm. These BmPGA
crystals typically reached approximate dimensions of 130  500  70 mm in 7 d. At
this magnification, a 60-unit length on the scale corresponds to an actual length of
1 mm.
3. Results and discussion
BmPGA was purified from extracellular medium to 95% homo-
geneity using a single-step purification protocol. The initial crystal-
lization trials produced clusters of layered plate-shaped crystals
within 2 d. Combinations of either sodium chloride or calcium
chloride, PEG 4000 and buffers in the pH range 6.0–7.5 represented
the best crystallizing solutions in the microbatch screening. Single
plate-shaped crystals of BmPGA were successfully grown after grid
refinement of selected conditions using the hanging-drop vapour-
diffusion technique. Using the optimized conditions, crystals appeared
within 3 d and grew to maximum dimensions in 7 d (Fig. 1).
A number of cryoprotectant solutions were tested by flash-cooling
the crystals under a cold nitrogen stream at 98 K prior to data
collection, with unsuccessful results. Although most of the tested
cryoprotectants allowed sample vitrification with no ice rings, the
crystals showed either no or very poor diffraction. A brief immersion
(5–30 s) of the crystals in cryoprotectant solutions that were similar to
the reservoir solution but with a 7–40% increase in the corresponding
crystallizing agent concentration and with or without 12–15%(v/v)
glycerol yielded diffraction patterns with streaked or blurred reflec-
tions at higher resolution despite sharp spots at low resolution (Fig. 2).
The high-resolution reflections appeared to be slightly less smeared
with a shorter cryoprotectant soak, yet the diffraction was still un-
suitable for data collection and structure determination. One of the
better diffracting crystals could be indexed in the monoclinic space
group P21, with unit-cell parameters a = 86.22, b= 78.15, c= 117.02 A˚,
 = 100.20. The molecular volume (Matthews coefficient; Matthews,
1968) was estimated to be 2.3 A˚3 Da1 with a calculated solvent
content of 46.3% assuming the presence of two molecules per
asymmetric unit. Attempts to minimize the soaking time did not
improve the diffraction. The smearing patterns led us to think that
there might be global conformational changes, perhaps with minor
rearrangement of the crystal packing, upon contact with the cryo-
solution, as the high-resolution data were more dramatically affected.
We then decided to leave some crystals to soak for longer in the
cryosolutions (150–200 ml in a sealed well), allowing the establish-
ment of a new conformation/packing equilibrium. Crystals soaked for
longer in the cryoprotectant solution showed brighter birefringence
under a polarized microscope and exhibited improved diffraction,
with sharp spots to beyond 2.5 A˚ resolution after overnight soaking.
One of the BmPGA crystals diffracted X-rays to 2.20 A˚ resolution in-
house with a 185 mm crystal-to-detector distance (Fig. 3). A total of
180 diffraction images were collected with an oscillation angle of 1
and an exposure time of 720 s per image. The crystal belonged to
the primitive monoclinic space group P21, with unit-cell parameters
a = 58.10, b = 77.84, c = 84.04 A˚,  = 101.02. A molecular volume of
2.2 A˚3 Da1 was obtained with a calculated solvent content of 44.0%
assuming one BmPGA molecule per asymmetric unit. The change in
unit-cell parameters supports our hypothesis of molecular
rearrangement. In this case, the BmPGA molecules apparently
reoriented such that the noncrystallographic symmetry that might
have been slightly off the b axis in the original lattice was moved
parallel to the b axis and essentially became the crystallographic
symmetry in the new packing. Thus, this allowed the new lattice to be
indexed with half the original unit-cell volume. Statistics of data
collection for the new cell are summarized in Table 1.
Initial phases for this BmPGA structure were solved with the
molecular-replacement method using the AMoRe program (Navaza,
1994) in the CCP4 program package (Winn et al., 2011; Dodson et al.,
1997). A known structure of native EcPGA (PDB entry 1pnm;
Duggleby et al., 1995), the amino-acid sequence of which shares 71%
homology (30% identity) with BmPGA, was used as a search model.
Using 15–3 A˚ resolution data, AMoRe successfully located a mole-
cule in the asymmetric unit with a correlation coefficient and R factor
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Figure 2
One of the best 1 oscillation photographs showing an X-ray diffraction pattern of a
BmPGA crystal obtained from a short soak in cryoprotectant prior to flash-cooling
under cold N2 gas. The resolution at the edges of the detector is 2.89 A˚. The
diffraction spots at higher resolution are typically fuzzier than those at lower
resolution.
Figure 3
A 1 oscillation image showing an X-ray diffraction pattern of a BmPGA crystal
soaked overnight in cryoprotectant solution consisting of 29%(m/v) PEG 4000,
0.2M calcium chloride, 0.1M imidazole pH 6.50 and 15%(v/v) glycerol. The
resolution at the edges of the detector is 1.98 A˚. Data were processed to 2.20 A˚
resolution.
of 30.12% and 55.34%, respectively (the corresponding values for the
second-best solution were 24.2% and 57.4%, respectively). Rigid-
body refinement and minimization of the resulting solution carried
out in the resolution range 50–2.8 A˚using the CNS program (Bru¨nger
et al., 1998) resulted in a drop in the R factor to 51.24%, with an Rfree
of 55.22%. The initial A-weighted 2mFo DFc electron-density map
showed well defined backbone density, allowing us to build a three-
dimensional structure of BmPGA. Crystallographic model rebuilding
and refinement are in progress.
This crystal form exemplifies how extended soaking time in a
cryoprotectant solution can improve X-ray diffraction quality in a
case where a short cryosoak does not work. Reduction in the solvent
content indicated that the overnight-soaked crystals were slightly
dehydrated by the cryosolution. A similar treatment was previously
reported for three unrelated proteins where crystals were dried for
15 min to several hours in small volumes of cryosolutions exposed to
open air (Abergel, 2004). Such an improvement of diffraction upon
crystal desiccation is thought to initiate rearrangement of protein
conformation throughout the crystals similar to that seen in the
dehydration of an HIV-1 reverse transcriptase crystal (Esnouf et al.,
1998; Abergel, 2004). Other successful crystal dehydration attempts
involved exposure to air, addition of dehydrating agents or equili-
bration with dehydrating solutions using a hanging-drop setup over a
period of minutes to months (Haebel et al., 2001; Heras et al., 2003;
Kuo et al., 2003; Heras & Martin, 2005; Sam et al., 2006). Some of
these techniques require multiple steps of crystal transfer or succes-
sive increments of dehydrating agent concentration to allow gradual
changes in the crystal environment. Some were also followed by
additional cryoprotecting steps prior to crystal vitrification. In our
case, the increase in crystallizing agent concentration in the cryo-
protectant solution was originally aimed to prevent crystal dissolution
as no additional BmPGA was present in the soaking solution. This
has been successfully used in our general crystal harvesting/preser-
vation protocol for many proteins crystallized with salt and PEG
combinations. Some crystal forms do not require such a gradual
change of crystal environment and can endure transfer with excess
liquid from the crystallization drops (2–10 ml) to the soaking solution
(100–200 ml) with no sacrifice of crystal mosaicity. However, the
increase in the concentration of crystallizing agent unintentionally
dehydrated the BmPGA crystals, inducing a conformational change,
and cryoprotected the crystal in the single soaking step. In addition,
our method of soaking in a sealed container offers better control of
the final conditions as well as reproducibility compared with an open-
air treatment, which may result in detrimental dehydration. The
presence of glycerol in the soaking of BmPGA crystals helped to
eliminate the occasional appearance of faint shadows from ice rings.
In crystal dehydration, the time required to reach equilibrium of the
new packing environment may vary for different crystal forms. The
soaking of BmPGA crystals was originally left overnight for con-
venience, although it was subsequently found with other similarly
treated crystals that improved birefringence could be observed after
a couple of hours of soaking. Hence, crystal birefringence under
polarized light may also serve as a crude detection of improvement in
crystal integrity. From these results, we propose that a long soaking in
cryoprotectant be tried as an alternative treatment for vitrification of
crystals in routine data collection, especially in cases where a short
cryoprotectant soak gives similar diffraction characteristics as were
observed in our case.
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